InvestorsHub Logo
Followers 9
Posts 4042
Boards Moderated 0
Alias Born 03/20/2001

Re: thewind post# 9944

Sunday, 04/23/2017 8:24:05 PM

Sunday, April 23, 2017 8:24:05 PM

Post# of 10487
Seems that way to me to. The new CEO's background isn't perfectly aligned to grow the tissue tox business. Seems to be more favorable towards the more expensive/highly dilutive liver patch side of the known plan. I wish they'd focus 95% of their time and energy on the tissue tox side of the business, get it to $20-30MM and then drive like crazy to be the primary supplier of 3D printed liver and kidney tissue to CROs.... THEN, and only then, increase their focus on a patch. If they're going to focus sooner than later on the liver patch... please, please, please name a well-heeled partner! I'd rather have 50% of something than 100% of nothing.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ONVO News